chr2:203853888:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr2:204,718,611-204,738,688 |
hg38 | chr2:203,853,888-203,873,965 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.008 | squamous cell carcinoma | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Cardiomyopathy, Dilated | NA | BeFree,GAD | Detail | |
0.175 | celiac disease | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.002 | brain ischemia | NA | GAD | Detail | |
0.003 | Malignant tumor of cervix | This meta-analysis indicates that CTLA-4 +6230G/A polymorphism may be associated... | BeFree | 24493286 | Detail |
0.005 | Uterine Cervical Neoplasm | NA | GAD | Detail | |
<0.001 | Chediak-Higashi syndrome | NA | BeFree | Detail | |
0.003 | Chlamydia Infections | NA | BeFree,GAD | Detail | |
0.005 | Primary biliary cirrhosis | Meta-analysis: the relationship between CTLA-4 +49 A/G polymorphism and primary ... | BeFree | 25942345 | Detail |
0.003 | Cholangitis, Sclerosing | NA | BeFree,GAD | Detail | |
<0.001 | cholestasis | NA | BeFree | Detail | |
0.002 | choriocarcinoma | NA | GAD | Detail | |
0.003 | Bronchitis, Chronic | NA | BeFree,GAD | Detail | |
<0.001 | colitis | NA | BeFree | Detail | |
0.031 | ulcerative colitis | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | Colonic Neoplasms | NA | GAD,LHGDN | Detail | |
0.001 | colorectal carcinoma | Five functional polymorphisms of B7/CD28 co-signaling molecules alter susceptibi... | BeFree | 25497975 | Detail |
0.001 | colorectal carcinoma | Individual and Combined Effects of CTLA4-CD28 Variants and Oxidant-Antioxidant S... | BeFree | 26408701 | Detail |
0.003 | Colorectal Neoplasms | NA | LHGDN | Detail | |
<0.001 | common cold | NA | BeFree | Detail | |
0.006 | common variable immunodeficiency | NA | BeFree,GAD | Detail | |
0.002 | Connective Tissue Diseases | NA | GAD | Detail | |
<0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
<0.001 | Coronary heart disease | NA | BeFree | Detail | |
0.015 | Crohn Disease | Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4... | BeFree,GAD,LHGDN | 25367873 | Detail |
<0.001 | Cytomegalovirus Infections | Human cytomegalovirus (CMV) infection has been implicated in accelerating immuno... | BeFree | 25943573 | Detail |
0.003 | Dengue Fever | NA | BeFree,GAD | Detail | |
<0.001 | Exfoliative dermatitis | NA | BeFree | Detail | |
0.007 | Dermatitis, Atopic | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | dermatomyositis | NA | BeFree | Detail | |
<0.001 | scleroderma | NA | BeFree | Detail | |
0.005 | Diabetes | There was significant association between the three CTLA-4 genotypes (AA, AG, GG... | BeFree | 26415372 | Detail |
0.008 | diabetes mellitus | There was significant association between the three CTLA-4 genotypes (AA, AG, GG... | BeFree,GAD | 26415372 | Detail |
0.248 | Diabetes Mellitus, Insulin-Dependent | Association analysis of PTPN22, CTLA4 and IFIH1 genes with type 1 diabetes in Co... | BeFree,GAD,GWASCAT,LHGDN | 25042601 | Detail |
0.248 | Diabetes Mellitus, Insulin-Dependent | Association of TCR/CD3, PTPN22, CD28 and ZAP70 gene polymorphisms with type 1 di... | BeFree,GAD,GWASCAT,LHGDN | 25448703 | Detail |
0.248 | Diabetes Mellitus, Insulin-Dependent | Detection of Cytotoxic T-Lymphocyte Associated Antigen-4 Gene Polymorphism in Ty... | BeFree,GAD,GWASCAT,LHGDN | 26415372 | Detail |
0.021 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree,GAD | Detail | |
<0.001 | diabetic ketoacidosis | NA | BeFree | Detail | |
0.002 | Eczema | NA | BeFree | Detail | |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
0.003 | Endocrine System Diseases | NA | BeFree,GAD | Detail | |
<0.001 | endometriosis | NA | BeFree | Detail | |
0.002 | Eosinophilia | NA | GAD | Detail | |
0.003 | erythema nodosum | NA | BeFree,GAD | Detail | |
0.002 | Disorder of eye | NA | BeFree | Detail | |
0.002 | Fatty Liver | NA | GAD | Detail | |
0.002 | Fetal Diseases | NA | GAD | Detail | |
0.003 | pathologic fistula | NA | LHGDN | Detail | |
<0.001 | Fuchs' heterochromic cyclitis | NA | BeFree | Detail | |
<0.001 | Gingival Diseases | NA | BeFree | Detail | |
0.003 | glomerulonephritis | NA | BeFree,LHGDN | Detail | |
<0.001 | membranous glomerulonephritis | NA | BeFree | Detail | |
0.131 | Graft-vs-Host Disease | NA | BeFree,CTD_human,GAD | Detail | |
0.005 | Hay fever | NA | GAD | Detail | |
0.002 | Heart Diseases | NA | GAD | Detail | |
<0.001 | Hematological Disease | NA | BeFree | Detail | |
0.010 | Hemophilia A | NA | BeFree,GAD | Detail | |
0.003 | Severe Dengue | NA | BeFree,GAD | Detail | |
<0.001 | hepatitis | NA | BeFree | Detail | |
<0.001 | hepatitis A | NA | BeFree | Detail | |
0.010 | hepatitis B | Associations of CTLA4 -318 and CD28 +17 with hepatitis B virus infection in allo... | BeFree,GAD | 24188429 | Detail |
0.002 | Hepatitis, Chronic | NA | GAD | Detail | |
0.013 | hepatitis C | NA | BeFree,GAD | Detail | |
<0.001 | Histiocytosis, Langerhans-Cell | NA | BeFree | Detail | |
0.018 | HIV Infections | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Hydatidiform mole | NA | GAD | Detail | |
<0.001 | hyperglycemia | NA | BeFree | Detail | |
0.005 | Immediate hypersensitivity | NA | GAD | Detail | |
<0.001 | hyperthyroidism | NA | BeFree | Detail | |
0.002 | hypoparathyroidism | NA | GAD | Detail | |
0.011 | hypothyroidism | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
0.001 | Immune System Diseases | NA | BeFree | Detail | |
0.017 | Inflammation | NA | GAD | Detail | |
0.009 | Inflammatory Bowel Diseases | NA | BeFree,GAD | Detail | |
0.001 | influenza | Our data suggest that influenza-specific humoral immunity is significantly influ... | BeFree | 25816015 | Detail |
0.003 | iridocyclitis | NA | LHGDN | Detail | |
<0.001 | arthropathy | NA | BeFree | Detail | |
<0.001 | Kidney Diseases | NA | BeFree | Detail | |
<0.001 | Kidney Failure, Chronic | NA | BeFree | Detail | |
0.005 | Kidney Neoplasm | NA | GAD | Detail | |
0.002 | Leishmaniasis, Cutaneous | NA | GAD | Detail | |
<0.001 | leprosy | NA | BeFree | Detail | |
<0.001 | Leprosy, Lepromatous | NA | BeFree | Detail | |
<0.001 | leukemia | NA | BeFree | Detail | |
0.004 | chronic lymphocytic leukemia | NA | BeFree,GAD | Detail | |
0.003 | lymphoid leukemia | NA | LHGDN | Detail | |
<0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
0.002 | myeloid leukemia | NA | GAD | Detail | |
<0.001 | Leukemia, Myelomonocytic, Chronic | NA | BeFree | Detail | |
0.120 | Adult T-Cell Lymphoma/Leukemia | NA | CTD_human | Detail | |
<0.001 | liver cirrhosis | NA | BeFree | Detail | |
0.007 | Liver Cirrhosis, Alcoholic | NA | GAD,LHGDN | Detail | |
0.019 | Biliary cirrhosis | NA | GAD,LHGDN | Detail | |
0.005 | Liver diseases | NA | GAD | Detail | |
0.005 | Alcoholic Liver Diseases | NA | GAD,LHGDN | Detail | |
0.005 | Liver neoplasms | NA | GAD | Detail | |
<0.001 | Lown-Ganong-Levine syndrome | NA | BeFree | Detail | |
0.003 | Chronic Obstructive Airway Disease | NA | BeFree,GAD | Detail | |
<0.001 | Lung Neoplasms | NA | BeFree | Detail | |
0.007 | Lupus Vulgaris | Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ i... | BeFree,GAD | 25786178 | Detail |
0.007 | Lupus Erythematosus, Discoid | Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ i... | BeFree,GAD | 25786178 | Detail |
<0.001 | Lupus Erythematosus, Subacute Cutaneous | NA | BeFree | Detail | |
0.068 | Lupus Erythematosus, Systemic | Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ i... | BeFree,GAD,LHGDN | 25786178 | Detail |
<0.001 | Lyme disease | NA | BeFree | Detail | |
<0.001 | lymphocytic choriomeningitis | C57BL/6 mice were inoculated with syngeneic B16F10 melanoma tumors transfected t... | BeFree | 25658614 | Detail |
0.002 | Lymphocytosis | NA | GAD | Detail | |
0.003 | Lymphohistiocytosis, Hemophagocytic | NA | BeFree,GAD | Detail | |
0.010 | lymphoma | NA | BeFree,GAD | Detail | |
<0.001 | Lymphoma, Follicular | NA | BeFree | Detail | |
0.008 | Lymphoma, Non-Hodgkin | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | lymphopenia | NA | BeFree | Detail | |
0.003 | Lymphoproliferative Disorders | NA | BeFree,GAD | Detail | |
0.003 | Malignant neoplasm of stomach | Analysis of promoter methylation, polymorphism and expression profile of cytotox... | BeFree,GAD | 25267951 | Detail |
0.002 | Animal Mammary Neoplasms | NA | GAD | Detail | |
0.137 | melanoma | Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity... | BeFree,CTD_human,GAD,LHGDN | 25658614 | Detail |
0.137 | melanoma | In melanoma patients treated with an immune checkpoint therapy, high viral defen... | BeFree,CTD_human,GAD,LHGDN | 26317466 | Detail |
0.002 | Meniere disease | NA | GAD | Detail | |
<0.001 | mitral valve stenosis | NA | BeFree | Detail | |
<0.001 | Monoclonal Gammopathy of Undetermined Significance | NA | BeFree | Detail | |
<0.001 | Mucocutaneous Lymph Node Syndrome | NA | BeFree | Detail | |
0.007 | multiple myeloma | NA | BeFree,GAD | Detail | |
0.064 | multiple sclerosis | IL-15 amplifies the pathogenic properties of CD4+CD28- T cells in multiple scler... | BeFree,GAD,LHGDN | 25617471 | Detail |
0.002 | Musculoskeletal Diseases | NA | GAD | Detail | |
0.029 | myasthenia gravis | Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age t... | BeFree,GAD,LHGDN | 24373506 | Detail |
0.029 | myasthenia gravis | CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gra... | BeFree,GAD,LHGDN | 25003519 | Detail |
<0.001 | Mycoses | NA | BeFree | Detail | |
0.003 | mycosis fungoides | NA | BeFree,LHGDN | Detail | |
0.003 | myocardial infarction | NA | BeFree,GAD | Detail | |
0.083 | myocarditis | NA | BeFree,LHGDN,RGD | Detail | |
0.009 | Neoplasm Metastasis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | nephritis | NA | BeFree | Detail | |
<0.001 | lipoid nephrosis | NA | BeFree | Detail | |
0.123 | oral submucous fibrosis | NA | BeFree,CTD_human,GAD | Detail | |
0.002 | osteosarcoma | We demonstrate that canine OS is positive for HER2, and that canine T cells expr... | BeFree | 25198528 | Detail |
0.002 | osteosarcoma | The objective of our study was to conduct a meta-analysis investigating the asso... | BeFree | 25230787 | Detail |
<0.001 | ovarian carcinoma | Clinically, from the largest ovarian cancer data set (GSE 9899, n = 285) availab... | BeFree | 25136802 | Detail |
0.003 | pancreatitis | NA | LHGDN | Detail | |
<0.001 | papilloma | NA | BeFree | Detail | |
<0.001 | paracoccidioidomycosis | NA | BeFree | Detail | |
0.005 | pemphigus | NA | BeFree,GAD | Detail | |
<0.001 | Periodontal Diseases | NA | BeFree | Detail | |
0.004 | periodontitis | NA | BeFree,LHGDN | Detail | |
<0.001 | Periodontitis, Juvenile | NA | BeFree | Detail | |
0.120 | Peripheral neuropathy | NA | BeFree,CTD_human | Detail | |
<0.001 | pneumonia | Here we showed that a lack of ICOS on murine ILC2s and blocking the ICOS:ICOS-li... | BeFree | 25769613 | Detail |
<0.001 | Post-kala-azar dermal leishmaniasis | NA | BeFree | Detail | |
0.005 | pre-eclampsia | NA | GAD | Detail | |
0.002 | Pregnancy Complications, Hematologic | NA | GAD | Detail | |
0.003 | Pretibial myxedema | NA | BeFree,GAD | Detail | |
0.003 | Prostatic Neoplasms | NA | LHGDN | Detail | |
0.002 | proteinuria | NA | GAD | Detail | |
0.011 | psoriasis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | pulmonary fibrosis | NA | BeFree | Detail | |
0.003 | purpura | NA | LHGDN | Detail | |
0.003 | Henoch-Schoenlein purpura | NA | BeFree,GAD | Detail | |
<0.001 | kidney failure | NA | BeFree | Detail | |
0.002 | Respiratory Syncytial Virus Infections | NA | GAD | Detail | |
0.002 | rhinitis | NA | GAD | Detail | |
0.002 | Rhinitis, Allergic, Perennial | NA | GAD | Detail | |
0.005 | sarcoidosis | NA | GAD | Detail | |
0.006 | schizophrenia | CTLA4 and CD28 Gene Polymorphisms with Respect to Affective Symptom Domain in Sc... | BeFree,GAD | 25998553 | Detail |
0.025 | systemic scleroderma | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | sialadenitis | NA | BeFree | Detail | |
0.003 | Dermatologic disorders | NA | BeFree,GAD | Detail | |
0.002 | Skin Neoplasms | NA | GAD | Detail | |
0.006 | ankylosing spondylitis | NA | BeFree,GAD | Detail | |
0.002 | aphthous stomatitis | NA | GAD | Detail | |
0.003 | Cerebrovascular accident | NA | BeFree,GAD | Detail | |
0.002 | subacute sclerosing panencephalitis | NA | GAD | Detail | |
0.002 | Sunburn | NA | GAD | Detail | |
<0.001 | tetanus | NA | BeFree | Detail | |
<0.001 | thalassemia | NA | BeFree | Detail | |
0.020 | Thyroid Diseases | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | thyroiditis | NA | BeFree | Detail | |
0.002 | trachoma | NA | GAD | Detail | |
0.003 | Chagas disease | NA | BeFree,GAD | Detail | |
0.003 | Tuberculosis, Pulmonary | NA | BeFree,GAD | Detail | |
<0.001 | urticaria | CTLA-4 polymorphism in the pathogenesis of chronic spontaneous autoreactive urti... | BeFree | 23597501 | Detail |
0.002 | anterior uveitis | NA | GAD | Detail | |
0.003 | Uveitis, Intermediate | NA | BeFree,GAD | Detail | |
0.005 | Uveomeningoencephalitic Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | vasculitis | NA | BeFree,GAD | Detail | |
0.002 | Virus Diseases | Associations of CTLA4 -318 and CD28 +17 with hepatitis B virus infection in allo... | BeFree | 24188429 | Detail |
0.015 | vitiligo | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Wiskott-Aldrich syndrome | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
0.002 | diffuse large B-cell lymphoma | NA | GAD | Detail | |
<0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
<0.001 | T-Cell Lymphoma | NA | BeFree | Detail | |
0.121 | Lymphoma, T-Cell, Cutaneous | NA | BeFree,CTD_human | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
0.005 | Bronchial Hyperreactivity | NA | BeFree,GAD | Detail | |
0.002 | Polyendocrinopathies, Autoimmune | NA | GAD | Detail | |
<0.001 | polymyositis | NA | BeFree | Detail | |
<0.001 | Polyglandular Type I Autoimmune Syndrome | NA | BeFree | Detail | |
0.007 | Pancreatitis, Chronic | NA | GAD | Detail | |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Primary Sj�gren's syndrome | NA | BeFree | Detail | |
0.005 | Premature Birth | NA | GAD | Detail | |
<0.001 | Non-arthropod borne lymphocytic choriomeningitis | C57BL/6 mice were inoculated with syngeneic B16F10 melanoma tumors transfected t... | BeFree | 25658614 | Detail |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | acute myocardial infarction | NA | BeFree | Detail | |
0.002 | allergic asthma | NA | BeFree | Detail | |
0.003 | Immunoglobulin A deficiency (disorder) | NA | BeFree,GAD | Detail | |
<0.001 | acute intermittent porphyria | NA | BeFree | Detail | |
<0.001 | Aortic Aneurysm, Abdominal | NA | BeFree | Detail | |
0.001 | Tumor Progression | NA | BeFree | Detail | |
0.002 | Diabetes, Autoimmune | Allelic variant in CTLA4 is associated with thyroid failure and faster β-cell ex... | BeFree | 25695113 | Detail |
<0.001 | Malignant ascites | NA | BeFree | Detail | |
<0.001 | Adult type dermatomyositis | NA | BeFree | Detail | |
<0.001 | Lesion of brain | Taken together, these findings indicate that increased peripheral and local leve... | BeFree | 25617471 | Detail |
<0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
<0.001 | Rheumatoid Vasculitis | NA | BeFree | Detail | |
0.012 | Hepatitis, Autoimmune | Meta-analysis: the relationship between CTLA-4 +49 A/G polymorphism and primary ... | BeFree,GAD | 25942345 | Detail |
<0.001 | Erectile dysfunction | NA | BeFree | Detail | |
0.005 | Malignant neoplasm of lung | NA | BeFree,GAD | Detail | |
<0.001 | Lyme Arthritis | NA | BeFree | Detail | |
<0.001 | age related macular degeneration | NA | BeFree | Detail | |
<0.001 | Neoplasm, Residual | NA | BeFree | Detail | |
0.003 | Mucosa-Associated Lymphoid Tissue Lymphoma | NA | LHGDN | Detail | |
<0.001 | pemphigus foliaceus | NA | BeFree | Detail | |
<0.001 | chronic urticaria | As the role of CTLA-4 polymorphism in autoimmune thyroid diseases is well proven... | BeFree | 23597501 | Detail |
<0.001 | Psoriasis vulgaris | NA | BeFree | Detail | |
<0.001 | Childhood asthma | NA | BeFree | Detail | |
<0.001 | Chronic Periodontitis | NA | BeFree | Detail | |
<0.001 | axonal neuropathy | NA | BeFree | Detail | |
<0.001 | Inflammatory neuropathy | NA | BeFree | Detail | |
0.003 | Postpartum Thyroiditis | NA | BeFree,GAD | Detail | |
<0.001 | Severe hereditary factor VIII deficiency disease | NA | BeFree | Detail | |
<0.001 | Pulmonary paracoccidioidomycosis | NA | BeFree | Detail | |
0.003 | Metastatic melanoma | Next, the first immune-activating anticytotoxic lymphocyte antigen-4 (CTLA-4) an... | BeFree | 25207460 | Detail |
0.003 | Metastatic melanoma | Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. | BeFree | 26359337 | Detail |
0.003 | cervical squamous cell carcinoma | NA | BeFree,GAD | Detail | |
0.010 | cervix carcinoma | This meta-analysis indicates that CTLA-4 +6230G/A polymorphism may be associated... | BeFree,GAD | 24493286 | Detail |
<0.001 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | NA | BeFree | Detail | |
0.022 | Thyroid associated opthalmopathies | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Stable angina | We evaluated both early and downstream T-cell receptor activation pathways after... | BeFree | 25814225 | Detail |
<0.001 | Ulcerative jejunitis | NA | BeFree | Detail | |
0.006 | Hypothyroidism, Autoimmune | NA | BeFree,GAD | Detail | |
<0.001 | Microscopic Polyangiitis | NA | BeFree | Detail | |
<0.001 | Asymptomatic human immunodeficiency virus infection | NA | BeFree | Detail | |
<0.001 | Chronic Chagas' disease | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
0.003 | prediabetes syndrome | NA | BeFree,GAD | Detail | |
<0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
<0.001 | Hereditary hemochromatosis | NA | BeFree | Detail | |
0.002 | Atopy | NA | GAD | Detail | |
0.003 | Multiple Sclerosis, Chronic Progressive | NA | LHGDN | Detail | |
0.003 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | NA | BeFree,GAD | Detail | |
0.005 | Immune thrombocytopenic purpura | NA | BeFree,GAD | Detail | |
<0.001 | Primary immune deficiency disorder | NA | BeFree | Detail | |
<0.001 | Idiopathic crescentic glomerulonephritis | NA | BeFree | Detail | |
<0.001 | Chronic rejection of renal transplant | NA | BeFree | Detail | |
0.023 | lupus erythematosus | Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ i... | BeFree,GAD | 25786178 | Detail |
<0.001 | Aortic valve calcification | NA | BeFree | Detail | |
<0.001 | neuropathy | NA | BeFree | Detail | |
<0.001 | Nephrotic range proteinuria | NA | BeFree | Detail | |
0.002 | Dermatitis and eczema | NA | GAD | Detail | |
<0.001 | Chlamydia trachomatis infection | NA | BeFree | Detail | |
0.001 | Granulomatosis | NA | BeFree | Detail | |
<0.001 | Metabolic syndrome X | NA | BeFree | Detail | |
0.008 | Hepatitis B, Chronic | NA | BeFree,GAD | Detail | |
0.006 | Hepatitis C, Chronic | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | primary sclerosing cholangitis | NA | BeFree | Detail | |
0.001 | Osteosarcoma of bone | We demonstrate that canine OS is positive for HER2, and that canine T cells expr... | BeFree | 25198528 | Detail |
<0.001 | Aqueous Humor Disorders | NA | BeFree | Detail | |
<0.001 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | Inherited neuropathies | NA | BeFree | Detail | |
<0.001 | Leukemogenesis | NA | BeFree | Detail | |
0.068 | Lupus Erythematosus, Systemic | CTLA-4 -1722T/C polymorphism and systemic lupus erythematosus susceptibility: a ... | BeFree | 23323522 | Detail |
0.068 | Lupus Erythematosus, Systemic | Overall, there was significant association between the 1722T/C polymorphism and ... | BeFree | 23922195 | Detail |
0.068 | Lupus Erythematosus, Systemic | CTLA-4 SNPs (CT60A/G, -1722T/C, -1661G/A, and -318C/T) and systemic lupus erythe... | BeFree | 24940764 | Detail |
0.025 | systemic scleroderma | We examined the relationship between five gene polymorphisms [cytotoxic T lympho... | BeFree | 22173230 | Detail |
<0.001 | Periodontitis, Juvenile | In addition, comparison of CTLA-4 SNPs between patients with CP and aggressive p... | BeFree | 22497911 | Detail |
<0.001 | prostate carcinoma | NA | BeFree | Detail | |
0.002 | breast carcinoma | This meta-analysis indicates that CTLA-4 +6230G/A polymorphism may be associated... | BeFree | 24493286 | Detail |
<0.001 | multiple pathologies | NA | BeFree | Detail | |
<0.001 | Carcinoma of lung | NA | BeFree | Detail | |
<0.001 | stomach carcinoma | Analysis of promoter methylation, polymorphism and expression profile of cytotox... | BeFree | 25267951 | Detail |
<0.001 | Carcinoma of bladder | Early results of clinical studies with anti-CTLA4 and anti-PDL1 are propelling i... | BeFree | 25498841 | Detail |
<0.001 | skin carcinoma | NA | BeFree | Detail | |
<0.001 | Hyperlipoproteinemia Type IIa | NA | BeFree | Detail | |
<0.001 | early pregnancy | NA | BeFree | Detail | |
<0.001 | Blood autoimmune disorders | NA | BeFree | Detail | |
0.002 | Acute GVH disease | A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibi... | BeFree | 25940108 | Detail |
0.003 | Thrombocytopenic purpura | NA | LHGDN | Detail | |
<0.001 | Chronic graft-versus-host disease | NA | BeFree | Detail | |
0.002 | Cardiomyopathies | NA | GAD | Detail | |
0.017 | autoimmune thyroiditis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | cancer regression | NA | BeFree | Detail | |
<0.001 | Acute coronary syndrome | NA | BeFree | Detail | |
0.003 | Spondylarthropathies | NA | BeFree,GAD | Detail | |
<0.001 | Arthritis, Collagen-Induced | NA | BeFree | Detail | |
0.080 | Arthritis, Experimental | NA | BeFree,RGD | Detail | |
<0.001 | Progressive multiple sclerosis | NA | BeFree | Detail | |
<0.001 | Invasive Ductal Breast Carcinoma | SNP-SNP interactions of immunity related genes involved in the CD28/B7 pathway w... | BeFree | 25900029 | Detail |
<0.001 | Malignant neoplasm of ovary | Clinically, from the largest ovarian cancer data set (GSE 9899, n = 285) availab... | BeFree | 25136802 | Detail |
<0.001 | diffuse scleroderma | NA | BeFree | Detail | |
<0.001 | Deficiency of vitamin D3 | NA | BeFree | Detail | |
<0.001 | Inflammatory disorder | NA | BeFree | Detail | |
<0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
<0.001 | Generalized vitiligo | NA | BeFree | Detail | |
<0.001 | Stage IV Skin Melanoma | NA | BeFree | Detail | |
<0.001 | autoimmune lymphoproliferative syndrome | Here we show that human ALPS DNT have features of terminally differentiated effe... | BeFree | 24894771 | Detail |
<0.001 | Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | NA | BeFree | Detail | |
<0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
0.001 | Sporadic Breast Carcinoma | NA | BeFree | Detail | |
0.002 | Cardiomyopathy, Familial Idiopathic | NA | GAD | Detail | |
0.005 | Mammary Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Human T-cell lymphotropic virus 1 infection | NA | BeFree | Detail | |
<0.001 | Salivary Gland Pleomorphic Adenoma | NA | BeFree | Detail | |
0.002 | Tumor Immunity | Importantly, blocking coinhibitory molecules using antibodies specific for CTLA-... | BeFree | 25527357 | Detail |
0.002 | Tumor Immunity | The discovery that antibody blockade of the T cell co-inhibitory receptor cytoto... | BeFree | 25555570 | Detail |
0.009 | colorectal cancer | Five functional polymorphisms of B7/CD28 co-signaling molecules alter susceptibi... | BeFree,GAD | 25497975 | Detail |
0.009 | colorectal cancer | Individual and Combined Effects of CTLA4-CD28 Variants and Oxidant-Antioxidant S... | BeFree,GAD | 26408701 | Detail |
0.005 | Sjogren's syndrome | NA | GAD | Detail | |
<0.001 | Glomerulonephritis, Minimal Change | NA | BeFree | Detail | |
<0.001 | bone sarcoma | The objective of our study was to conduct a meta-analysis investigating the asso... | BeFree | 25230787 | Detail |
<0.001 | Non-Neoplastic Disorder | In sharp contrast with TAMG, we now find that: i) CTLA4(low) +49G(+) genotypes w... | BeFree | 24373506 | Detail |
0.120 | DIABETES MELLITUS, INSULIN-DEPENDENT, 12 | NA | CTD_human | Detail | |
<0.001 | IMMUNE SUPPRESSION | Studies with human T cells blocked for CD28 and with T cells from CD28 knockout ... | BeFree | 25792524 | Detail |
<0.001 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | NA | BeFree | Detail | |
<0.001 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | NA | BeFree | Detail | |
0.002 | Venous thromboembolism | NA | GAD | Detail | |
0.003 | coronary artery disease | NA | BeFree,GAD | Detail | |
<0.001 | Latent autoimmune diabetes mellitus in adult | The frequency of CTLA4 G alleles and genotypes in LADA patients did not differ s... | BeFree | 25695113 | Detail |
<0.001 | Vasculitic neuropathy | NA | BeFree | Detail | |
0.003 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,GAD | Detail | |
0.002 | Proteinuria Adverse Event | NA | GAD | Detail | |
0.005 | liver carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
<0.001 | CD40 ligand deficiency | NA | BeFree | Detail | |
<0.001 | Allergic rhinitis (disorder) | NA | BeFree | Detail | |
<0.001 | autoimmune pancreatitis | NA | BeFree | Detail | |
0.003 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | NA | BeFree,GAD | Detail | |
0.007 | Chronic ulcerative colitis | NA | GAD | Detail | |
0.002 | Solar Erythema | NA | GAD | Detail | |
0.126 | Juvenile arthritis | NA | BeFree,CTD_human,GAD | Detail | |
0.012 | granulomatosis with polyangiitis | NA | GAD,LHGDN | Detail | |
0.002 | Thyroid associated orbitopathy | NA | GAD | Detail | |
0.001 | Allergic disposition | NA | BeFree | Detail | |
<0.001 | Allergic sensitization | NA | BeFree | Detail | |
0.013 | Infection | NA | GAD,LHGDN | Detail | |
<0.001 | juvenile rheumatoid arthritis | NA | BeFree | Detail | |
<0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
0.240 | AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V | NA | ORPHANET,UNIPROT | Detail | |
0.002 | Spontaneous abortion | NA | GAD | Detail | |
0.002 | Abruptio Placentae | NA | GAD | Detail | |
0.007 | Addison Disease | NA | GAD | Detail | |
0.003 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Affective Symptoms | CTLA4 and CD28 Gene Polymorphisms with Respect to Affective Symptom Domain in Sc... | BeFree | 25998553 | Detail |
0.122 | alopecia areata | NA | CTD_human,GAD | Detail | |
0.003 | anemia | NA | BeFree,GAD | Detail | |
0.006 | autoimmune hemolytic anemia | NA | BeFree,LHGDN | Detail | |
<0.001 | Angina, Unstable | NA | BeFree | Detail | |
<0.001 | Antibody Deficiency Syndrome | NA | BeFree | Detail | |
<0.001 | arteriosclerosis | NA | BeFree | Detail | |
0.006 | arthritis | NA | BeFree,GAD | Detail | |
<0.001 | Arthritis, Adjuvant-Induced | NA | BeFree | Detail | |
0.002 | Arthritis, Psoriatic | NA | GAD | Detail | |
0.345 | rheumatoid arthritis | Killer cell immunoglobulin-like receptors (KIR) expressed on surface of natural ... | BeFree,CTD_human,GAD,GWASCAT,LHGDN | 24912006 | Detail |
0.345 | rheumatoid arthritis | Non-HLA single nucleotide polymorphisms (SNPs) in the intergenic regions LOC3892... | BeFree,CTD_human,GAD,GWASCAT,LHGDN | 25014791 | Detail |
0.345 | rheumatoid arthritis | The expansion of CD4(+)CD28(null) cells in RA patients was associated with TNFA ... | BeFree,CTD_human,GAD,GWASCAT,LHGDN | 25510954 | Detail |
0.345 | rheumatoid arthritis | Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) +49 A>G gene polymorphism i... | BeFree,CTD_human,GAD,GWASCAT,LHGDN | 25542810 | Detail |
0.345 | rheumatoid arthritis | CTLA-4 and FoxP3 expression was measured by flow cytometry and quantitative poly... | BeFree,CTD_human,GAD,GWASCAT,LHGDN | 25604080 | Detail |
0.038 | asthma | Here we showed that a lack of ICOS on murine ILC2s and blocking the ICOS:ICOS-li... | BeFree,GAD,LHGDN | 25769613 | Detail |
<0.001 | atherosclerosis | NA | BeFree | Detail | |
0.002 | Autoimmune Response | NA | GAD | Detail | |
<0.001 | Melanoma, B16 | NA | BeFree | Detail | |
<0.001 | Bacterial Infections | NA | BeFree | Detail | |
<0.001 | Mental disorders | NA | BeFree | Detail | |
0.019 | Behcet Syndrome | NA | BeFree,GAD | Detail | |
0.003 | bipolar disorder | NA | BeFree,LHGDN | Detail | |
0.003 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
<0.001 | Bone neoplasms | NA | BeFree | Detail | |
0.009 | Malignant neoplasm of breast | This meta-analysis indicates that CTLA-4 +6230G/A polymorphism may be associated... | BeFree,GAD | 24493286 | Detail |
0.003 | bronchiolitis | NA | LHGDN | Detail | |
0.002 | Bronchiolitis, Viral | NA | GAD | Detail | |
0.002 | calcinosis | NA | GAD | Detail | |
<0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
0.002 | basal cell carcinoma | NA | GAD | Detail | |
<0.001 | Noninfiltrating Intraductal Carcinoma | The more aggressive DCIS-C1 (highly proliferative, basal-like, or ERBB2(+)) disp... | BeFree | 26249178 | Detail |
0.002 | Non-small cell lung carcinoma | Recent early phase studies of immune checkpoint modulators, such as CTLA-4, PD-1... | BeFree | 24880938 | Detail |
0.005 | renal cell carcinoma | NA | BeFree,GAD | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This meta-analysis indicates that CTLA-4 +6230G/A polymorphism may be associated with a decreased ri... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Meta-analysis: the relationship between CTLA-4 +49 A/G polymorphism and primary biliary cirrhosis an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Five functional polymorphisms of B7/CD28 co-signaling molecules alter susceptibility to colorectal c... | DisGeNET | Detail |
Individual and Combined Effects of CTLA4-CD28 Variants and Oxidant-Antioxidant Status on the Develop... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4. | DisGeNET | Detail |
Human cytomegalovirus (CMV) infection has been implicated in accelerating immunosenescence by shrink... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
There was significant association between the three CTLA-4 genotypes (AA, AG, GG) and diabetic compl... | DisGeNET | Detail |
There was significant association between the three CTLA-4 genotypes (AA, AG, GG) and diabetic compl... | DisGeNET | Detail |
Association analysis of PTPN22, CTLA4 and IFIH1 genes with type 1 diabetes in Colombian families. | DisGeNET | Detail |
Association of TCR/CD3, PTPN22, CD28 and ZAP70 gene polymorphisms with type 1 diabetes risk in Tunis... | DisGeNET | Detail |
Detection of Cytotoxic T-Lymphocyte Associated Antigen-4 Gene Polymorphism in Type 1 Diabetes Mellit... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Associations of CTLA4 -318 and CD28 +17 with hepatitis B virus infection in allogeneic hematopoietic... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our data suggest that influenza-specific humoral immunity is significantly influenced by age, and th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus... | DisGeNET | Detail |
Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus... | DisGeNET | Detail |
NA | DisGeNET | Detail |
C57BL/6 mice were inoculated with syngeneic B16F10 melanoma tumors transfected to express low levels... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analysis of promoter methylation, polymorphism and expression profile of cytotoxic T-lymphocyte-asso... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity in mice. | DisGeNET | Detail |
In melanoma patients treated with an immune checkpoint therapy, high viral defense signature express... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
IL-15 amplifies the pathogenic properties of CD4+CD28- T cells in multiple sclerosis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïv... | DisGeNET | Detail |
CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chin... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We demonstrate that canine OS is positive for HER2, and that canine T cells expressing a HER2-specif... | DisGeNET | Detail |
The objective of our study was to conduct a meta-analysis investigating the associations between CTL... | DisGeNET | Detail |
Clinically, from the largest ovarian cancer data set (GSE 9899, n = 285) available in GEO, high leve... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here we showed that a lack of ICOS on murine ILC2s and blocking the ICOS:ICOS-ligand interaction in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CTLA4 and CD28 Gene Polymorphisms with Respect to Affective Symptom Domain in Schizophrenia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CTLA-4 polymorphism in the pathogenesis of chronic spontaneous autoreactive urticaria. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Associations of CTLA4 -318 and CD28 +17 with hepatitis B virus infection in allogeneic hematopoietic... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
C57BL/6 mice were inoculated with syngeneic B16F10 melanoma tumors transfected to express low levels... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Allelic variant in CTLA4 is associated with thyroid failure and faster β-cell exhaustion in latent a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, these findings indicate that increased peripheral and local levels of IL-15 amplify ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Meta-analysis: the relationship between CTLA-4 +49 A/G polymorphism and primary biliary cirrhosis an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
As the role of CTLA-4 polymorphism in autoimmune thyroid diseases is well proven we speculated on th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Next, the first immune-activating anticytotoxic lymphocyte antigen-4 (CTLA-4) antibody ipilimumab ex... | DisGeNET | Detail |
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
This meta-analysis indicates that CTLA-4 +6230G/A polymorphism may be associated with a decreased ri... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We evaluated both early and downstream T-cell receptor activation pathways after ex vivo stimulation... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We demonstrate that canine OS is positive for HER2, and that canine T cells expressing a HER2-specif... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CTLA-4 -1722T/C polymorphism and systemic lupus erythematosus susceptibility: a meta-analysis involv... | DisGeNET | Detail |
Overall, there was significant association between the 1722T/C polymorphism and overall SLE risks (O... | DisGeNET | Detail |
CTLA-4 SNPs (CT60A/G, -1722T/C, -1661G/A, and -318C/T) and systemic lupus erythematosus: a meta-anal... | DisGeNET | Detail |
We examined the relationship between five gene polymorphisms [cytotoxic T lymphocyte associated anti... | DisGeNET | Detail |
In addition, comparison of CTLA-4 SNPs between patients with CP and aggressive periodontitis (AgP) r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
This meta-analysis indicates that CTLA-4 +6230G/A polymorphism may be associated with a decreased ri... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analysis of promoter methylation, polymorphism and expression profile of cytotoxic T-lymphocyte-asso... | DisGeNET | Detail |
Early results of clinical studies with anti-CTLA4 and anti-PDL1 are propelling immune modulating dru... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
SNP-SNP interactions of immunity related genes involved in the CD28/B7 pathway with susceptibility t... | DisGeNET | Detail |
Clinically, from the largest ovarian cancer data set (GSE 9899, n = 285) available in GEO, high leve... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here we show that human ALPS DNT have features of terminally differentiated effector memory T cells ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Importantly, blocking coinhibitory molecules using antibodies specific for CTLA-4 and PD-1 enhances ... | DisGeNET | Detail |
The discovery that antibody blockade of the T cell co-inhibitory receptor cytotoxic T lymphocyte-ass... | DisGeNET | Detail |
Five functional polymorphisms of B7/CD28 co-signaling molecules alter susceptibility to colorectal c... | DisGeNET | Detail |
Individual and Combined Effects of CTLA4-CD28 Variants and Oxidant-Antioxidant Status on the Develop... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The objective of our study was to conduct a meta-analysis investigating the associations between CTL... | DisGeNET | Detail |
In sharp contrast with TAMG, we now find that: i) CTLA4(low) +49G(+) genotypes were more frequent (p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Studies with human T cells blocked for CD28 and with T cells from CD28 knockout mice demonstrated th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The frequency of CTLA4 G alleles and genotypes in LADA patients did not differ significantly from th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
CTLA4 and CD28 Gene Polymorphisms with Respect to Affective Symptom Domain in Schizophrenia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Killer cell immunoglobulin-like receptors (KIR) expressed on surface of natural killer cells and CD2... | DisGeNET | Detail |
Non-HLA single nucleotide polymorphisms (SNPs) in the intergenic regions LOC389203|RBPJ, LOC10013113... | DisGeNET | Detail |
The expansion of CD4(+)CD28(null) cells in RA patients was associated with TNFA genotype, even at di... | DisGeNET | Detail |
Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) +49 A>G gene polymorphism in Egyptian cases wit... | DisGeNET | Detail |
CTLA-4 and FoxP3 expression was measured by flow cytometry and quantitative polymerase chain reactio... | DisGeNET | Detail |
Here we showed that a lack of ICOS on murine ILC2s and blocking the ICOS:ICOS-ligand interaction in ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This meta-analysis indicates that CTLA-4 +6230G/A polymorphism may be associated with a decreased ri... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The more aggressive DCIS-C1 (highly proliferative, basal-like, or ERBB2(+)) displayed signatures cha... | DisGeNET | Detail |
Recent early phase studies of immune checkpoint modulators, such as CTLA-4, PD-1 and PD-L1 inhibitor... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386609373 dbSNP
- Genome
- hg38
- Position
- chr2:203,853,888-203,873,965
- Variant Type
- snv
Genome browser